Goldenisia, Quite a constellation of symptoms,
Post# of 148326
Quite a constellation of symptoms, and likely divergent/heterogenous pathology as Dr Patterson has indicated.
Many markers being evaluated in addition to symptoms. Also the reason LH trial is phase 2 (as essentially Cd12 ended up with old/young, severe/critical dichotomies).
LL will not address the entirety of LH symptoms. I sit do not care for the dismissive “analysis” in the WSJ article.
Many, many acclaimed physicians very concerned with the disability from LH.